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TOBACCO SMOKING AS A POTENTIAL RISK FACTOR FOR PULMONARY
TUBERCULOSIS: A MET A-ANALYSIS
ABSTRACT
Objective. The aim of this paper was to systematically evaluate available evidence on 
tobacco smoking as a risk factor for pulmonary tuberculosis.
Methods. Relevant reports were identified by a systematic electronic search of 
Medline, Pubmed, Nioshtic, Toxline and Embasse. Methodological quality of all 
selected publications was assessed using a standardized checklist. Information was 
collected on all major study characteristics. Inter-study heterogeneity was examined 
qualitatively and statistically using the DerSimonian and Laird method.
Results. Five case-control studies and 1 cohort study were included in the systematic 
review. All the 6 studies revealed a relationship between tobacco smoking and 
pulmonary tuberculosis. Heterogeneity across studies hampered overall statistical 
pooling of results, however pooled risk ratios for sub-groups were determined. 
Conclusion. Tobacco smoking is a potential risk factor for pulmonary tuberculosis. 
Confirmation would require prospective cohort studies conducted in countries with 
high tuberculosis incidence. Adequate sample sizes and adjustment for potential 
confounders including alcohol, HIV/AIDS, poverty and passive smoking are essential 
requirements.
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ABBREVIATIONS
AIDS Acquired immunity deficiency syndrome
BCG Bacille Calmette Guerin
Cl Confidence Interval
CIs Confidence intervals
df Degrees of freedom
HIV Human Immunodeficiency virus
N/A Not applicable
OR Odds ratio
ORs Odds ratios
PTB Pulmonary tuberculosis
RR Risk ratio
RRs Risk ratios
SE Standard error
SES Social Economic Status
TB Tuberculosis
Vs Versus
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1. BACKGROUND
Evidence that smoking tobacco is harmful to health has been accumulating for 200 
years1. The medical profession and the general public had nonetheless ignored the 
evidence on tobacco prior to 19501. In 1950 case-control studies were done attributing 
lung cancer to tobacco smoking1. Large prospective and retrospective studies have 
shown a significant association between cigarette smoking and several cardiovascular 
and pulmonary diseases, in particular chronic obstructive pulmonary disease, chronic 
lung disease, stomach, oesophageal and liver cancers, pulmonary tuberculosis (PTB), 
stroke and ischaemic heart disease ’ . Tobacco kills 4 million people a year worldwide, 
and by the early 2030s the figure will increase to about 10 million. Seventy percent 
(70%) of these deaths will occur in developing countries4.
TB is a global public health problem5. It is the leading cause of mortality among 
infectious diseases5. Worldwide the disease kills about 1.87 million a year and results 
in 7.96 million new cases a year6. The incidence of TB has increased in the majority of 
countries primarily due to its association with the human immunodeficiency virus 
(HIV) epidemic and other conditions including migration, homelessness, poverty, 
addictions and lack of health care resources5’7,8.
Tobacco smoking has been cited as a risk factor for PTB but few studies worldwide 
have assessed the association of tobacco smoke and PTB4. Retrospective and 
prospective studies, of large numbers of subjects, that have cited the relationship 
between tobacco smoking and PTB, were not initially planned to test the hypothesis 
that tobacco smoke is related to the disease1,3,9. The studies aimed at assessing health 
hazards associated with use of tobacco in general. Case-control studies done in Spain
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and USA, aimed at testing the hypothesis that tobacco smoking is a risk factor for PTB, 
have shown evidence of an association10,11’12. However, cohort studies would be strong 
designs to assess a potential relationship between tobacco smoking and PTB. Only one 
cohort study was found in the current systematic review.
1.1 AIM
The aim of this paper was to systematically evaluate available evidence on tobacco 
smoking as a risk factor for PTB.
1.2 JUSTIFICATION
There is a disagreement in the English literature as to whether tobacco smoking is 
independently associated with PTB. Systematic reviews are instrumental in resolving 
uncertainty when reports disagree, increasing sample sizes, hence statistical power, and 
estimating true effects of a risk factor13. A meta-analysis or review can hardly prove or 
disapprove causality; however it is instrumental in exploring the basis for differences 
among studies and in the process providing evidence bearing on causal inference14, as 
well as identifying proper methods for future studies on causation.
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1.3 LITERATURE REVIEW
1.3.1 ACTIVE TOBACCO SMOKING AND PTB MORTALITY
Doll et al1 reported on findings from a prospective study of mortality in relation to 
smoking habits assessed over a 40 year period, from 1951 to 1991. The objective of the 
study was to assess hazards associated with long-term use of tobacco in a cohort of 
British male doctors. The study demonstrated that PTB has a moderately close relation 
with smoking. From 1951 to 1991, 66 subjects developed PTB. A standardized trend 
test indicated a significant increase in mortality from PTB with increased number of 
cigarettes smoked per day, p <0.001. This finding is in agreement with findings by Liu 
et al3 and Lam et al9. Liu et al3 compared smoking habits of people who died of 
neoplastic, respiratory or vascular causes and a reference group who died of other 
causes between 1986 and 1988. The study revealed that PTB caused about 5 to 8% of 
all tobacco attributed deaths3. The study indicated that among men aged 35 to 65 there 
was a dose response relation between age when started smoking and the risk of dying 
from PTB. Lam et al9 replicated these findings. In their study, cases were all deaths 
that were registered in Hong Kong in 1998. Controls were living persons suffering 
from diseases other than neoplastic, vascular and respiratory illnesses. This study 
revealed a much greater association between PTB mortality and tobacco smoking than 
the one done by Liu et al3, as shown in table 1.3.1.
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Table 1.3.1. RRs (95% Cl) comparing PTB mortality between smokers and non- 
smokers, China and Hong Kong.
Study RR (95 % Cl)
Men aged Women aged 35-
35-69 yrs 69 yrs
Lam et al9 (Hong Kong) 2.54(1.24-5.22) 1.49(0.18-2.57)
Liu et al3 (China) 1.2(1.12-1.28) 1.29(1.13-1.45)
1.3.2 TOBACCO SMOKING AND DEVELOPMENT OF ACTIVE PTB
Alcaide et al10 showed that cigarette smoking is a risk factor for PTB in young adults in 
a study done in 1992. They reported a dose response relationship between number of 
cigarettes consumed per day and risk of developing active disease. They indicated that 
young adult smokers who were contacts of index PTB patients were at a higher risk of 
disease than those not exposed to tobacco smoke, OR =3.7 (95% Cl 1.5 to 9.2)10. This 
study is in agreement with results by Doll et al1, Lam et al9 and Liu et al3. Doll et al1 
observed that when TB was an important cause of mortality in Britain, mortality from 
PTB was strongly related to smoking1.
If a cohort study similar to the one done by Doll1 were done in a developing country, 
with high incidence of TB mortality, researchers could get more convincing results. 
Results of a study done in Tiruvallur district, India, in the year 2000, showed an 
association between tobacco smoking and PTB OR= 2.5 (95% Cl 1.6 to 4.2)15. The 
ratio of cases to controls was 1:5. Only a summary of this study is available on the 
Internet and it seems that the study has not been published yet in international English 
journals. This study had an adequate number of controls and was done in a setting in 
which PTB is more prevalent compared to Britain and Spain. A similar study done in
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King County, USA in 1990 showed that the risk of PTB among smokers of 30 years or 
more, is 2.6 times the risk of non-smokers".
1.3.3 PASSIVE SMOKING AND PTB
Cotinine, a metabolite of nicotine is the best biochemical marker for quantifying 
passive exposure to smoking16. It is specific to tobacco and has a half-life of about 20 
hours and can be detected at low concentrations16. Cook et al17 reported that passive 
smoking is a problem especially within homes. At least 50% of children, aged 5 to 7 
years, included in the study done in England and Wales were exposed to tobacco 
smoke . Cook et al indicated that maternal smoking is more important than paternal 
smoking, despite the lower levels of smoking by mothers. They showed that children 
not exposed at home had a low cotinine concentration, which depended on the 
prevalence of smoking in the community17. In a study of 7-year-old children attending 
school in Edinburgh, Scotland, it was reported that three quarters of the children from 
non-smoking households had detectable salivary cotinine, suggesting that factors other 
than smoking by household members may be significant regarding exposure to some 
children18. Altet et al12 assessed the effect of passive smoking within the family on the 
development of active PTB in children less than 15 years. The study, done in 1992, 
revealed that passive exposure to tobacco smoke in children was associated with an 
increased risk of developing active PTB, immediately following infection with 
Mycobacterium tuberculosis. Children exposed to tobacco smoke (through passive 
smoking) were at a higher risk of developing PTB compared to those not exposed, 
OR=5.4 (95% Cl 2.4 to 11.9).
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1.3.4 ROLE OF CONFOUNDERS IN THE ASSOCIATION BETWEEN
TOBACCO SMOKING AND PTB
Studies investigating the association between tobacco and PTB are complex, as the 
number of potential confounders is potentially large4. For that reason the studies must 
control for confounding factors including alcohol consumption, HIV/AIDS status, 
intravenous drug use, malnutrition, sanitation and social status. The association 
between alcohol and tobacco smoking is well known1. In some settings persons who 
drink heavily and abuse tobacco are more likely to be homeless or live in squatter 
camps11’19. These are at an increased risk of exposure to M. tuberculosis11. In addition 
heavy drinking may increase the risk of progression to active PTB through poor eating 
habits and inadequate nutrition11. Failure to adjust for confounders will lead to false 
conclusions about tobacco smoking as a risk factor for PTB. Levy et al20 observed that 
the roles of alcohol, HIV infection and intravenous drug use should be taken into 
consideration when investigating the association between tobacco and PTB. He 
suggested that a cohort study was needed to assess the relationship. Yach4 also stated 
that results from a prospective study on the link between tobacco and PTB would be 
important. Cohort studies designed to assess the causal relationship between smoking 
and PTB should consider carefully the role of alcohol alone, smoking alone and the 
interaction of the two. It is also crucial to allow for the latent period of exposure to 
tobacco smoke, as done by Lam et al9 and Liu et a l3’.
A matched case-control study aiming at assessing the relationship between personal 
behaviour (smoking and alcohol consumption) and PTB was done in Chengdu, China
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in 1996, with 173 cases and 173 controls*. It showed no independent relationship 
between tobacco smoking and TB21. Univariate analysis showed that active and passive 
smoking were significantly associated with PTB, OR=2.12, p-value=0.006 and 
OR=1.55, p-value=0.04 respectively21. However, multivariate logistic regression 
analysis showed no evidence of independent associations between PTB and smoking or 
PTB and alcohol consumption. The study showed that smokers who took alcohol were 
at a higher risk of developing PTB, OR =7.73 (95% Cl 1.52 to 39) 21. The study 
concluded that smoking and alcohol were not independently associated with PTB21. 
This study is not in accord with studies that have shown that alcohol alone or smoking 
alone are risk factors for PTB l’3,9’10’11’22.
1.3.5 INADEQUATE LITERATURE ON THE INFLUENCE OF TOBACCO 
SMOKING ON PTB
Yach4 like most researchers interested in the association between smoking and PTB 
noted the inadequacy of studies on the topic. He pointed out that available evidence 
suggests that TB infection, incidence and severity, are related to tobacco use4. There is 
some clinical evidence suggesting that patients who continue to smoke after starting 
treatment seem to take longer to improve both clinically and bacteriologically4. Yach4 
believes that tobacco is likely the major cause of death among treated TB patients4. 
Further research on the relationship between tobacco and TB is needed.
* Only the abstract was available in English, full report was in Chinese
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2 MATERIALS AND METHODS
2.1 SEARCH STRATEGY
Research papers were retrieved by a computerized search of Medline, Pubmed, 
Nioshtic, Toxline and Embasse for publications dating from 1991 to 2001. The 
following key words were used (MeSH headings and text words): tobacco, 
smoking, smoker, smoke, risk factors, cigarette, cigars, pipes, mortality, alcohol, 
tuberculosis, pulmonary, respiratory, addiction, environmental, pollution, case- 
control, cohort, passive smoking, meta-analysis and review. In addition a rigorous 
physical search was done in the Witwatersrand Medical School Library using 
references of the identified relevant studies. Papers not available in South Africa 
were ordered from abroad.
2.2 SELECTION CRITERIA
Studies were included in the systematic review if they met the conditions listed 
below:
i. Citing relationship between tobacco smoking and PTB
ii. Longitudinal in design; case-control or cohort.
iii. Full reports published in English in peer-reviewed journals.
iv. Information on risk factors for PTB available
v. Exposure assessed by interviews or questionnaires on smoking habits.
vi. Date of publication 1991 through 2001
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2.3 QUALITY ASSESSMENT
Studies have differences in methodological quality. Consequently results of some 
are certainly more affected by bias compared to others. Quality was taken into 
account in assessing the potential association between smoking and PTB. A 
modified version of the checklist for quality appraisal used by Danielle AW Van 
der Windt23 was developed. The following components of a paper; objective, 
selection of participants, exposure ascertainment, analysis and data presentation 
were scored as follows:
• Positive (+) if bias was minimal.
• Negative (-) if there was potential bias.
• Unknown (?) if information was insufficient or not available.
Details of the standardised checklist are shown in table 2.3.1. Each item shown in 
table 2.3.1 was scored as either positive (+), negative (-) or unknown (?) for all the 
studies included in this systematic review. The total number of positive scores was 
determined for each study. The proportion of positive scores was calculated for 
each study (number of positive scores divided by number of applicable items). 
Thereafter studies were ranked in order of methodological quality whereby a study 
with the largest proportion of positive scores was ranked as number 1.
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Table 2.3.1. Standardised checklist for the assessment of methodological quality 
across studies included in this systematic review.
Item______ Description of Methodological Item___________________________________
STUDY OBJECTIVE
1 Clearly stated objective
SELECTION OF PARTICIPANTS (applicable for case control studies)
2 Cases and controls clearly defined
3 Cases and controls selected from the same source population
EXPOSURE ASSESSMENT
4 Adequate*  information on exposure to tobacco smoke presented
5 Major confounders adjusted for
6 Subjects categorised into exposure groups according to levels of exposure
ANALYSIS AND DATA PRESENTATION
7 Both univariate and multivariate analysis performed
8 RRs and ORs and their 95% Cl or SE displayed
9 ________ Sample size adequate________________________________________________
* Adequate information include average number o f  cigarettes per day and duration o f  smoking
2.4 EXCLUDED STUDIES
Papers whose abstracts were in English but full reports were available in other 
languages were excluded in the systematic review. Studies that investigated the 
relationship between tobacco smoking and primary infection with Mycobacterium 
tuberculosis were not included. Unpublished papers were also omitted in the 
current systematic review.
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2.5 DATA EXTRACTION AND ANALYSIS
Details for each study included in the systematic review were extracted on; study 
site, dates, study population, exclusion and inclusion criteria, exposure and 
outcome ascertainment, detection of cases, confounders and RR or OR with their 
95% CIs. Pooled risk estimates were determined only when homogeneity was 
statistically proved in sub-groups of studies included in the current systematic 
review. Homogeneity in meta-analysis is constancy of exposure effect across 
studies or between defined strata across studies24. Heterogeneity may be defined as 
variability or differences among studies in estimates of exposure effects.
The DerSimonian and Laird random effects approach was used to assess 
homogeneity across studies24,25. A Q statistic, which has a chi-square distribution 
with df 1 less than the number of studies pooled, was used to test a null hypothesis 
of constant exposure effect across studies (Ho: homogeneity of results vs Ha: 
heterogeneity of results). The Mantel-Haenszel fixed effect model26 was used to 
combine ORs for subgroups of studies whose results were proved to be 
homogeneous (see Appendix for details on the DerSimonian and Laird method).
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2.6 LIMITATIONS
Limitations of this review include existence of few studies investigating the causal 
association between tobacco smoking and PTB, the majority of which are case- 
control studies. Only one prospective study was identified in the English literature. 
Furthermore this review only considered papers published in peer-reviewed 
journals. Publication bias can therefore not be ruled out. Finally, enormous 
heterogeneity impeded overall statistical pooling of results.
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3 RESULTS
3.1 SEARCH RESULTS
The search of the computerised databases yielded 126 citations on TB and tobacco in 
the English literature. Only 41 studies on the causal association between tobacco 
smoking and TB were cited. This number was reduced to 25 when only abstracts dated 
1991 to 2001 and those published in peer reviewed journals were included. After 
excluding publications looking at TB primary infection and reviews on TB and 
tobacco, only 6 studies were included in the systematic review.
Computerised search of 
databases: 126 citations excluded -----------►
85 abstracts not related to 
the topic of this review
v
41 abstracts excluded 16 abstracts (published
selected and read w before 1991)
r 19 papers on M. tuberculosis
25 full papers excluded infection and reviews on TB
retrieved and read W and tobacco smoking
included
6 studies
Figure 3.1.1.Flow diagram showing papers accepted and excluded for systematic 
review
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The majority of studies reported effects of tobacco smoking on health with emphasis 
on cancers, heart disease, asthma and other pulmonary diseases other than TB. 
Similarly the majority of studies done on risk factors for TB did not assess tobacco 
smoking as a potential risk factor. Five cases-control studies and one cohort study 
were included in this systematic review.
3.2. STUDY CHARACTERISTICS
Table 3.2.1 presents a summary of study characteristics including study site, dates, 
population study, study design, inclusion criteria, exposure and disease ascertainment, 
and confounders. The table also presents multivariate RRs and ORs with 95% CIs. A 
wide variety of study settings across papers were observed. Differences in study 
characteristics are discussed in section 3.4, page 31. Exposure ascertainment was 
similar in all studies in such a way that questionnaires and direct interviews were 
administered.
Studies by Alcaide et al10 and Altet et al12 were similar regarding materials and 
methods and were all done in Barcelona, Spain. These studies were very different in 
design from those conducted by Liu et al3 and Lam et al9.
Cases in the studies by Lam et al9 and Liu et al3 were deaths from neoplastic, 
respiratory or vascular causes. These were all case control studies with large numbers 
of subjects.
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The study by Doll et al1 was different from the rest in design. It was a cohort study 
with a very long follow-up period of 40 years1. This study also included a large number 
of subjects1 as shown in table 3.2.1. Doll et al1 did not present an RR for PTB mortality 
in the paper included for this systematic review. However, Doll27 indicated in a later 
review paper that the mortality ratio of PTB comparing smokers to non-smokers was 
2.8 for the British male doctors cohort.
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Table 3.2.1. Characteristics of studies that were included for the systematic review
Item Case control studies Cohort
study
Author A ltet et a l12 Lam et al9 Buskin et 
al11
Alcaide et a l10 Liu et a l3 Doll et a l1
S ite B a rc e lo n a - S p a in H o n g  K o n g K ing  
C o u n ty  - 
U S A
B a rc e lo n a -S p a in M a in la n d
C h in a
B rita in
D a te s 1 9 9 2 1 9 9 8 1 9 8 8 -
1 9 9 0
1 9 9 2 1 9 8 9 -
1991
1 9 5 1 -19 91
S tu d y
p o p u la tio n
C h ild re n  < 1 5  
y e a rs  w h o  w e re  
c o n ta c ts  o f  in d e x  
T B  c a s e s  
re p o rt in g  to  
‘C e n tre  d e  
P re v e n c io  i 
C o n tro l d e  la  
T u b e rc u lo s i' in 
B a rc e lo n a
Ethnic Chinese 
people aged 
above 35 
years whose 
deaths were 
registered in 
1998 and 
people w ho 
knew  the dead 
peoples' 
sm oking habits
K ing
C o u n ty
re s id e n ts
a g e d
a b o v e  17
y e a rs
s e e k in g
c a re  a t
K ing
C o u n ty
T B  C lin ic
Y o u n g  a d u lts  1 5 -2 4  
y e a rs , w h o  w e re  
c o n ta c ts  o f  in d e x  P T B  
c a s e s  re p o rt in g  to  
‘C e n tre  d e  P re v e n c io  
i C o n tro l d e  la  
T u b e rc u lo s i' in 
B a rc e lo n a
C h in e s e  
p e o p le  
a g e d  35  
y e a rs  a n d  
a b o v e
A ll
re g is te re d
B ritis h
m a le
d o c to rs
S a m p le
s iz e
9 3  c a s e s  
9 5  c o n tro ls
27507 cases 
13054 controls
151 c a s e s  
545controls
4 6  c a s e s  
4 6  c o n tro ls
0.7 m illion 
cases and 
0.2 m illion 
controls
A  cohort o f 
34 439 
British male 
doctors
In c lu s io n
c r ite r ia
T u b e rc u lin  te s t 
p o s it iv e .
C lo s e  c o n ta c ts  o f  
in d e x  P T B  
p a t ie n ts  s e e k in g  
c lin ic  c a re .
Registered 
deaths in 1998 
and people 
w ho knew  the 
dead peoples' 
sm oking 
habits.
R e s id e n ts  
th a t w e re  
m e n ta lly  
c o m p e te n t 
s e e k in g  
c lin ic  c a re  
a t K ing  
C o u n ty  
C lin ic .
T u b e rc u lin  te s t 
p o s itiv e .
C lo s e  c o n ta c ts  o f  
in d e x  P T B  p a tie n ts  
s e e k in g  c lin ic  c a re .
People 
w ho d ied in 
1986-88 in 
China. 
Subjects 
w ho ever 
sm oked 
before 
1980.
D o c to rs  on  
th e  B ritish  
m e d ic a l 
re g is te r.
E x c lu s io n
c r ite r ia
Tuberculin  test 
negative children 
w ere  not included. 
Those taking 
isoniazid
chem oprophylaxis. 
BCG vaccinated. 
A ctive  sm okers. 
C ontacts o f sm ear 
negative index PTB 
patients.
Non-C hinese 
people were 
not included. 
W ives of 
registered 
dead people 
not recruited 
as controls.
P a tie n ts  
< 1 7  y e a rs  
o f  a ge . 
T h o s e  n o t 
s e e k in g  
c a re  a t T B  
C lin ic . 
H IV /A ID  
p a tie n ts .
T u b e rc u lin  te s t  
n e g a tiv e .
B C G  v a c c in a te d  
in d iv id u a ls .
K n o w n  p re v io u s  
c h e m o p ro p h y la x is .  
Im m u n o c o m p ro m is e d  
p a tie n ts  o r  th o s e  w ith  
o th e r  c o n d it io n s  
a s s o c ia te d  w ith  r is k  
fa c to rs  fo r  T B .
D eaths
before
1986 and
afte r 1988.
Sm okers
who
started
sm oking
after 1980.
Non
Chinese
people.
Doctors
struck off
m edical
register.
Doctors lost
to fo llow  up.
Non-British
doctors and
fem ale
British
doctors.
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Author A ltet et a l12 Lam et al9 Buskin et a l11 A lcaide et a l10 Liu et a l3 Doll et a l1
E x p o s u re
m e a s u re m e n t
Q u e s t io n n a ire s
w e re
a d m in is te re d  to  
s m o k in g  fa m ily  
m e m b e rs .
U rin a ry
c o n c e n tra t io n  o f  
c o t in in e  w a s  
determ ined by 
specific
radio im m unoassay.
Q uestionnaires 
about sm oking 
habits o f the 
deceased 
w ere  given 
to  people 
registering 
deaths of 
re latives and 
friends.
S e lf
a d m in is te re d  
q u e s tio n n a ire s  
to  a ll s u b je c ts .
Q u e s t io n n a ire s
w e re
a d m in is te re d  to  
s u b je c ts .
U rin a ry
c o n c e n tra t io n  o f  
cotin ine  w as 
determ ined by 
specific
rad io im m unoassay
In te rv ie w s  o f
s u rv iv in g
fa m ily
m e m b e rs  on  
s m o k in g  
h a b its  o f  th e  
d e c e a s e d .
D o c to rs  w e re  
s e n t
q u e s tio n n a ire s  
o n  s m o k in g  
h ab its .
Q u e s tio n n a ire s  
w e re  s e n t to  
d o c to rs  in 
1 9 5 7 ,1 9 6 6 ,  
1 9 7 2 ,1 9 7 8  
a n d  1990.
C a se
d e fin it io n
M . tu b e rc u lo s is  
c u ltu re  p o s it iv e  
o r  a  c o m b in a t io n  
o f  c lin ic a l 
e v id e n c e , 
ra d io lo g ic a l 
e v id e n c e  a n d  a 
p o s it iv e  
tu b e rc u lin  tes t.
N o t
s p e c if ie d 3
L a b o ra to ry
c o n firm a tio n
o f
M. tuberculosis
C u ltu re  p o s it iv e  
o r  a c o m b in a t io n  
o f  c lin ic a l a n d  
ra d io lo g ic a l 
e v id e n c e  a n d  a 
p o s it iv e  
tu b e rc u lin  tes t.
N o t s p e c if ie d 3 N o t s p e c if ie d b
C a s e  f in d in g S u b je c ts  w e re  
c o n ta c ts  o f  in d e x  
P T B  c a s e s  
s e e k in g  c lin ic a l 
c a re  a t  th e  T B  
C lin ic .
D a ta  on  
c a s e s  w a s  
re tr ie v e d  
fro m  d e a th  
re g is tr ie s  
(c a s e s  w e re  
d e a th s  
re g is te re d  in 
1 9 9 8 ).
R e c ru itm e n t o f  
p a tie n ts  
s e e k in g  c a re  
a t K ing  
C o u n ty  C lin ic .
S u b je c ts  w e re  
c o n ta c ts  o f  in d e x  
P T B  c a s e s  
s e e k in g  c lin ic a l 
c a re  a t th e  T B  
C lin ic .
D e ta ils  a b o u t 
d e a th s  w e re  
re tr ie v e d  fro m  
m e d ic a l 
re c o rd s  a n d  
lo ca l
a d m in is tra t io n
re c o rd s .
M o rta lity  
in fo rm a tio n  
w a s  s o u rc e d  
fro m  th e  O ffice  
o f  P o p u la tio n  
C e n s u s  a nd  
S u rve ys ,
B M J and  
M e d ic a l 
D ire c to ry  
o b itu a r ie s .
C o n fo u n d e rs
c o n s id e re d
A g e , se x , S E S , 
c ro w d in g  a n d  
s m o k in g  h a b its .
A g e , sex , 
e m p lo y m e n t,  
a n d  h o u se  
typ e .
W e ig h t, 
h e ig h t, a g e , 
se x , S E S  a n d  
a lc o h o l.
S m o k in g  h a b its , 
a g e , g e n d e r  a n d  
S E S .
N o . o f  
c ig a re tte s , 
a g e  w h e n  
s ta rte d  
s m o k in g  a n d  
re s id e n c e  
(ru ra l o r 
u rb a n )
D rin k in g  
h a b its , h e a lth  
h is to ry  a nd  
a sp ir in  use .
R  R  o r  O R  
a nd
(9 5 %  C l)
O R  =  5 .3 9  
(9 5 %  C l 
2 .4 4 - 1 1 . 9 1 )
R R C= 2 .5 4  
(9 5 %  C l 
1 .2 4 - 5 .2 2 )
O R  = 2 .6  
(9 5 %  C l 
1 . 1 - 5 . 9 )
O R = 3 .6 5  
(9 5 %  C l 
1 .4 6 - 9 .2 1 )
R R C= 1 .2 
(9 5 %  C l 
1 .1 2 - 1 . 2 8 )
R R = 2 .8 d 
(9 5 %  C l n o t 
g iv e n )
“This was a case-control study with a large number of subjects aimed at assessing different causes of mortality 
associated with tobacco smoking.
bThis was a cohort study aimed at assessing all health hazards associated with long term use of tobacco.
c Risk ratios for smokers vs non-smokers were estimated using logistic regression. 
d Refer to reference number 27
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3.2.1 EXPOSURE TO TOBACCO SMOKE
Studies categorized exposure groups in a different way as shown in tables 3.2.2 
and 3.2.3. Altet et al12 categorized exposure as: passive smoker in homes, passive 
smoker both within homes and outside the home (whereby active smokers were 
family members) and number of cigarettes smoked by family members12. Alcaide 
et al10 divided exposure groups into active smokers, passive and active smokers, 
daily smokers, occasional smokers and number of cigarettes smoked. Liu et al3 
and Doll et al1 categorized exposure by number of cigarettes smoked per day. 
Altet et al12, Buskin et al11 and Alcaide et al10 collected detailed information on 
exposure to tobacco smoke.
Table 3.2.2. Reported findings on dose response relationship between numbers of 
cigarettes smoked per day and risk of PTB morbidity and mortality across studies 
included in the current review
C ig are ttes  
S m o ked  per
C a s e  c o n tro l s tu d ies  
w ith  d ead  cases
C ase  contro l s tu d ies  w ith  liv in g  cases C o h o rt
stu d y
day L a m Liu A lc a id e B u s k in A lte t D o ll e t  a l1
e t  a l9 e t a l3 R R e t a l10O R e t a l11O R e t a l12 O R (M o rta lity 0 p e r
R R a (9 5 % C I)b (9 5 %  C l) (9 5 %  C l) (9 5 %  C l) 100,000 m e n )
1 -1 4 1 .0 2 7
5 -1 5 1 .4 (0 .8 -2 .6 )
1 -2 0 1 .2 (1 .1 -1 .4 ) 3 (1 .3 -7 .9 ) 1 .6 (0 .7 -2 .6 )
1 5 -2 4 2 .9 3 9
= 2 0 1 .5 (1 .3 -1 .6 )
1 6 -2 9 1 .9 (1 .1 -3 .4 )
> 2 0 6 .6 2 2 .0 ( 1 .8 - 2 .3 ) 1 3 (2 .3 -7 4 ) 4 (1 .6 -9 .8 ) 2 0
> 3 0 2 .9 (1 .2 -7 .2 )
> 4 0 7 .8 (3 .4 -1 8 )
a test for trend p-value < 0.001
b 95% CIs determined from given standard errors o f  RR in the paper
c standardized trend test1, has expectation zero and a standard deviation o f  unity values above 
3.29 correspond to p-value <0.001.
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Alcaide et al10 reported that the risk of developing PTB is highest if one is both an 
active and passive smoker, followed by active smoking alone and then passive 
smoking only (see table 3.2.3).
Table 3.2.3. Dose response relationship between smoking habits and risk of 
developing PTB, Spanish case-control studies10,12.
Exposure to Alcaide et al10 Altet et al12
Tobacco smoke OR (95% Cl) OR (95% Cl)
Passive only 2.50(1.00-6.2) 5.39(2.44-11.91)
Occasional/daily 3.6(1.5-2.2) -
Daily 3.5(1.3-9.3) -
Active & passive 5.6(2.1-15.1) -
3.3 METHODOLOGICAL QUALITY RESULTS
Table 3.3.1 displays results of the assessment of methodological quality across 
studies. The columns in the table show scores for each methodological item, 
whereas the rows represent studies (names of first authors). The studies are ranked 
according to the proportion of positive scores.
Methodological item 5 (adjustment of major confounders) had negative scores for 
studies by Lam et al9, Liu et al3 and Alcaide et al10. The case-control study by 
Alcaide et al10 was also scored negative for having a small sample size. The 
sample size of 46 cases and 46 controls was small for this study28,29. Studies by 
Altet et al12 and Buskin et al11 scored positive for all major methodological items. 
Their sample sizes were adequate and major confounding factors were controlled 
for. Failure to adjust for alcohol in the study by Altet et al12 was acceptable
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because the study population was children under the age of 15 years. Buskin et 
al11 effectively controlled for alcohol and social economic status. Furthermore 
they validated their findings by using population-based data to calculate age- 
adjusted ORs and 95% their CIs. All studies presented RRs or ORs with CIs 
except Doll et al1.
All items of the methodological checklist received equal weight. This has the 
disadvantage that studies with few, but important flaws may still be ranked as one 
of the best. As shown in table 3.3.1 the quality of the studies included in this 
review was high.
Table 3.3.1. Results of the assessment of methodological quality across studies 
included in this systematic review.
Study (first authors)
L a m 9 A l t e t 12 A lc a id e 10 L iu 3 D o l l1 B u s k in 11
Y e a r 1 9 9 8 199 2 1 9 9 2 1 9 8 9 -
1991
1 9 5 1 -
1991
1 9 8 8 -
1 9 9 0
S ite  H o n g K o n g S pa in S p a in C h in a B rita in U S A
D e s ig n 3 c c c c c c c c ch c c
M e th o d o lo g ic a l  I te m *
1. C le a r  o b je c t iv e s + + + + + +
2. W e ll d e fin e d + + + + N /A +
c a s e s /c o n tro ls
3. C a s e s /c o n tro ls  fro m + + + + N /A +
s a m e  p o p u la tio n
4 . In fo rm a tio n  o n  to b a c c o + + + + + +
s m o k e  e x p o s u re
5 .M a jo r  c o n fo u n d e rs - + - - + +
a d ju s te d  fo r
6 .S m o k e rs  c la s s ifie d  b y  N o. + + + + + +
o f  c ig a re tte s  p e r  d a y
7 .M u lt iv a r ia te  a n a ly s is  d o n e + + + + + +
8. O R  o r  R R  w ith  9 5 %  C l + + + + ? +
p re s e n te d
9. S a m p le  s iz e  a d e q u a te 11 + + - + + +
P ro p o rt io n  o f  p o s it iv e 0 .8 0 1 .0 0 0 .7 8 0 .7 8 0 .8 6 1 .0 0
s c o re s
R a n k  a c c o rd in g  to  s c o re 4 1.5 5 .5 5 .5 3 1 .5
a cc = Case control study
ch = Cohort study
* methodological items listed in full in table 2.3.1. Items are scored “+” for minimal bias, “-’’for potential 
bias, “ ?” for insufficient/unavailable information and “N/A” if item not applicable. 
b Fleiss equation for determining sample size: comparison of proportions in 2 groups26.
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3.4 SUB-GROUP POOLED ESTIMATES
Homogeneity and Heterogeneity
The terms homogeneity and heterogeneity are defined in the data extraction and 
analysis section (section 2.5, page 21). Studies are homogenous if they are measuring 
a constant exposure effect and differences in the measures of effects are only due to 
random error24.
There were differences in characteristics of studies included in this systematic review 
regarding; age ranges of participants, definition of cases and controls, confounders 
considered, statistical models, exclusion and inclusion criteria as shown in table 3.2.1. 
Lam et al9 and Liu et al3 included subjects aged 35 years and above. Alcaide et al10 
enrolled participants aged between 15 and 24 years, while Altet et al12 recruited 
children less than 15 years of age. Buskin et al11 included subjects aged above 17 
years. Doll et al1 included registered British male doctors of all ages.
Studies by Lam et al9 and Liu et al3 defined cases as deaths due to different 
respiratory, neoplastic or vascular causes. But these studies had different controls. 
Lam et al9 used living relatives and friends who knew the deceased’s smoking habits 
as controls whereas Liu et al3 defined controls as people dying of other deaths other 
than neoplastic, vascular and respiratory causes. These two case control studies were 
treated as a separate stratum in meta-analysis. Doll et al1 also investigated respiratory, 
neoplastic or vascular causes related to tobacco smoking among the British male 
doctors cohort. This review was however only interested in deaths and cases of PTB.
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The study by Doll et al1 was the only cohort study and its data was not pooled with 
that from case control studies.
Alcaide et al’°, Altet et al12 and Buskin et al11 defined cases as PTB patients who 
either were culture positive, smear positive, or a combination of clinical evidence, 
radiological evidence and a tuberculin positive test. These used subjects without PTB 
as controls. In studies by Alcaide et al10 and Altet et al12 controls were tuberculin 
positive individuals.
Different inclusion and exclusion criteria were observed across studies as shown in 
table 3.2.1. Alcaide et al10 excluded immuno-compromised patients or those with 
conditions associated with risk factors for TB (table 3.2.1, page 26). Similarly Buskin 
et al11 and Altet et al12 excluded HIV positive subjects (table 3.21, page 26). Buskin et 
aln excluded mentally incompetent patients. Alcaide et al10 and Altet et al12 excluded 
subjects who took chemoprophylaxis or received a BCG vaccine. Alcaide et al10 and 
Altet et al12 were also treated as a sub-group in meta-analysis.
Liu et al3 and Lam et al9 only included registered deaths. Ninety percent (90%) of all 
deaths are registered in China, where Liu et al3 conducted their study. Lam et al9 
indicated that in Hong Kong where they conducted their study, death registration is a 
requirement by law. Bias due to exclusion of unregistered deaths was therefore 
minimal.
All investigators for studies included in this systematic review controlled for age, sex, 
social economic status and smoking habits (including number of tobacco cigarettes
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smoked per day). Table 3.4.1 indicates different confounders that were controlled for 
and adjusted RRs and ORs. Buskin et al11 further adjusted for alcohol, duration of 
smoking, weight and height. In addition to the already mentioned confounders, Liu et 
al3 controlled for smoking duration and residence (rural or urban). Doll et al1 further 
controlled for health history and aspirin use. Alcaide et al10 also controlled for nature 
of exposure, whether active or passive tobacco smoking. In addition to confounders 
mentioned above Altet et al12 further adjusted for crowding and number of smoking 
family members.
Table 3.4.1. Adjusted RRs and ORs determined in studies included in this systematic 
review and the confounders adjusted for.
Study Confounders 
adjusted for
Adjusted RRs or ORs 
(95% Cl)
Comments
Altet et al12 Sex, age, father's SES 
and cigarettes/day.
Passive smoking vs PTB
morbidity
5.4(2.4-11.9)
Major confounders were 
adjusted for. HIV/AIDS 
patients were excluded
Alcaide et 
al10
Age, se x , number of 
cigarettes/day and 
SES.
Active smoking vs PTB 
morbidity:
3.6(1.4-9.5)
Active and passive smoking 
vs PTB morbidity: 
5.7(1.9-17.5)
Considering age of 
participants (15-24yrs) should 
have controlled for alcohol. 
Immunocompromised patients 
were excluded
Buskin et al11 Age, cigarettes/day 
alcohol and SES.
Active smoking for more 
than 30years vs PTB 
morbidity:
2.6(1.1-5.9)
Major confounders were 
adjusted for. HIV/AIDS 
patients were excluded
Lam et al9 Age and education Active smoking \/s PTB 
mortality:
2.54( 1.24-5.22)
Alcohol was not adjusted for
Liu et al3 Cigarettes/day, 
residence, sex and 
age.
Active smoking vs PTB 
mortality: 
1.2(1.12-1.28)
Alcohol was not adjusted for
Doll et al1 Cigarettes/day and sex Active smoking vs PTB 
mortality:
2.8 (Cl not given)
Drinking habits were 
controlled for. This was a 
strong study design for the 
association under study
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Differences in study characteristic were the reason for heterogeneity of results across 
studies included in the current systematic review. Using the DerSimonian and Laird 
approach as described in the data extraction and analysis section (section 2.5, page 
21), heterogeneity was assessed among all the 5 case control studies included in this 
review. The study by Doll et al1 was not included in the heterogeneity assessment 
because not all data required for the calculation of the variance for loge OR was 
available. There was evidence of heterogeneity across all the 5 case control studies 
with a Q statistic=15, df= 4, p-value <0.01 as shown in table 3.4.2.
The Forest Plot30 shown in figure 3.4.1 shows, at a glance, differences in exposure 
effect estimates across studies. The L’Abbe' plot, figure 3.4.2, one of graphical 
methods suggested for exploring heterogeneity of results in a systematic review,30 
graphically shows heterogeneity in results of the 5 case-control studies.
The study by Lam et al9 had the lowest values of mortality rates, 2% among non- 
smoker and 4% among smokers, followed by Liu et al3. Alcaide et al had highest PTB 
morbidity rates 33% among non-smokers and 65% among smokers, followed by Altet 
et al. This shows that study design and age of participants played a big role in 
heterogeneity of results.
Results of studies by Alcaide et al10, Altet et al12 and Buskin et al11 were 
heterogeneous as shown in table 3.4.3. However there was no evidence of 
heterogeneity of results in studies by Alcaide et al10 and Buskin et al11 Q statistic=2.2, 
df=l, p-value>0.1 (table 3.4.4). There was also no evidence of heterogeneity of
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results between Alcaide et al10 and Altet et al12, Q statistical).4, df=l, p-value >0.1 
(table 3.4.5).
There was no evidence of heterogeneity of results between studies by Liu et al3 and 
Lam et al9, Q statistic=1.8, df=l, p-value>0.1 (table 3.4.6). Heterogeneity of results 
impeded pooling of results across studies. ORs of all subgroups of studies that were 
statistically proved to be homogeneous were pooled using the Mantel-Haenszel 
approach26.
Tables 3.4.2 to 3.4.6 show results of DerSimonian and Laird heterogeneity test 
results. These tables also display pooled subgroup Mantel-Haenszel ORs for study 
subgroups that were homogeneous.
T ab le  3.4.2.
review.
Heterogeneity assessment in all studies included in this systematic
Study Smokers Non
smokers
Wt (%)» OR (95%CI )*
PTB(yes/no) PTB(yes/no)
Altet et al12 83/58 10/37 0.93 5.3 (2.3-12.4)
Buskin et al11 103/300 48/245 3.82 1.75(1.2-2.6)
Alcaide et al10 33/19 13/27 0.74 3.6 (1.4-9.5)
Liu et al3 2371/18544 1003/12165 93.3 1.55(1.4-1.7)
Lam et al9 36/841 11/639 1.2 2.5(1.2-5.2)
Doll et al1 - - 2.8 ( - )
DerSimonian and Laird Q statistic= 
HETEROGENEITY
15, df=4, p-value <0.01. THERE IS EVIDENCE OF
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a wt = % weight assigned to each study (weight =inverse o f  variance o f  loge OR) 
* See detailed results in the appendix
Table 3.4.3. Heterogeneity assessment and meta-analysis of case-control studies 
investigating the association between PTB morbidity and tobacco smoking in subjects
of all ages.
Study Smokers
PTB(yes/no)
Non
smokers
PTB(yes/no)
Wta
(%)
OR*
(95%CI)
Altet et al12 83/58 10/37 17 5.3(2.3-12.4)
Buskin et al11 103/300 48/245 70 1.75(1.2-2.6)
Alcaide et al10 33/19 13/27 13 3.6(1.4-9.5)
DerSimonian and Laird Q statistic=7.4, df =2, p-value <0.05. THERE IS EVIDENCE OF 
HETEROGENEITY. POOLING OF RESULTS NOT VALID
a wt = % weight assigned to each study (weight =inverse o f  variance o f  loge OR) 
* See detailed results in the appendix
Table 3.4.4. Heterogeneity assessment and meta-analysis of case-control studies 
investigating the association between PTB morbidity and active tobacco smoking in 
subjects aged 17 years and above.
Study Smokers Non
smokers
Wt
(%)
OR
(95%CI Fixed)
PTB(yes/no) PTB(yes/no)
Buskin et al11 103/300 48/245 84 1.75(1.2-2.6)
Alcaide et al10 33/19 13/27 16 3.6(1.4-9.5)
Mantel-Haenszel OR = 1.97(1.37-2.86)
DerSimonian and Laird Q statistic 
HETEROGENEITY
=2.2, df=1, p-value>0.1. NO EVIDENCE OF
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Table 3.4.5. Heterogeneity assessment and meta-analysis of case-control studies 
investigating the association between PTB morbidity and tobacco smoking in Spanish 
subjects aged 25 years and below.
Study Smokers Non
smokers
Wt
(%)
OR
(95%CI Fixed)
PTB(yes/no) PTB(yes/no)
Altet et al12 83/58 10/37 56 5.3(2.3-12.4)
Alcaide et al10 33/19 13/27 44 3.6(1.4-9.5)
Mantel-Haenszel OR = 4.51 (2.44-8.32)
DerSimonian and Laird Q statistic=0.417, df=1, p-value >0.1. 
OF HETEROGENEITY
THERE IS NO EVIDENCE
Table 3.4.6 Heterogeneity assessment and meta-analysis of case-control studies 
investigating the association between PTB mortality and tobacco smoking in Chinese 
subjects aged between 35 and 69 years.
Study Smokers Non
smokers
Wt
(%)
OR
(95%CI Fixed)
PTB(yes/no) PTB(yes/no)
Liu et al3 2371/18544 1003/12165 98.7 1.55(1.4-1.7)
Lam et al9 36/841 11/639 1.3 2.5(1.2-5.2)
Mantel Haenszel OR = 1.56 (1.44-1.69)
DerSimonian and Laird Q statistic^.81, df=1, p-value >0.1. THERE IS NO EVIDENCE 
OF HETEROGENEITY
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The Forest Plot shown in figure 3.4.1 shows differences in exposure effect estimates 
across studies. The diamonds represent ORs and RRs, while the lines across them 
represent 95% CIs. The size of each diamond roughly corresponds to the sample size 
in each primary study or subgroup of studies.
Study OR*
Odds ratio (95% Cl) (95%CI)
Altet et al12 -------------- ♦ -------------- 5.3(2.3-12.4)
Buskin et al11 > - 1.75(1.2-2.6)
Alcaide et al10 _____♦_______________ 3.6(14-9.5)
Liu et al3 ♦ 1.6(14-1.7))
Lam et al9 2.5(1.2-5.2)
Doll et al1
♦ 2.8 ( - )
Spanish subjects 4.51 (244-8.32)
aged 25 years and ----------* __________
below1012
Chinese Subjects
aged between 35 ♦ 1.6(1.44-1.69)
and 69 years39
- 1 1 3 5 7 S 
O R
11 13
♦The size of each diamond roughly corresponds to the sample size of each study or subgroup of studies.
Figure 3.4.1. Forest plot showing differences in exposure effect across primary 
studies and subgroups of studies included in the systematic review
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The L’Abbe' plot in figure 3.4.2 shows heterogeneity in results of the 5 case-control 
studies. Each dot represents an individual study. The dotted diagonal line represents 
the line of equality of mortality or morbidity rates between smokers and non- 
smokers30. It can be seen that mortality or morbidity rates varied greatly among both 
non-smokers (2% to 33%) and smokers (4% to 65%) across studies. The study by 
Doll et al1 was not included in the L’Abbe' plot because it was very different in 
design and was done in a very long period of time (1951 to 1991).
Percentage of PTB cases or deaths in each 
study included in review
% ( sm okers)
Figure 3.4.2. L’Abbe' Plot: Graphically showing heterogeneity of results across 
studies included in this systematic review.
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4. DISCUSSION
4.1 HETEROGENEITY
This systematic review evaluated results of 6 studies, 5 case control studies and 1 
cohort study on the association between tobacco smoking and PTB. The review found 
substantial heterogeneity across the six studies included in the systematic review. 
Heterogeneity across studies in estimates of exposure effect was statistical, 
methodological and clinical30.
Statistical differences arose from different sample sizes and statistical models used. 
Studies with small samples resulted into lower precision of risk estimates as compared 
to those with large samples. This is evidenced by wider CIs for studies by Alcaide et 
al10 and Altet et al12 as compared to those by Liu et al3, Lam et al9 and Buskin et al11, 
which had large numbers of subjects.
Sources of methodological heterogeneity included differences in techniques for 
measurement of exposure to tobacco smoke, inclusion and exclusion criteria, study 
design, objectives and the definition of cases and controls.
Clinical heterogeneity was a result of differences in participants’ characteristics 
including age, race and possibly different types of tobacco.
Heterogeneity of results hampered sensible overall statistical pooling of results. As a 
result a qualitative summary was undertaken. However heterogeneity was further
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assessed in subgroups of studies. Weighted estimates of ORs were determined in 
subgroups of studies using the Mantel Haenszel fixed effect model26.
All studies in this review used different categories for levels of exposure to tobacco 
smoke (number of cigarettes/day or other categories). In addition, complete 
categorical data on exposure status for subjects of different sexes, social status groups, 
age groups and other confounders was not presented. This made it difficult to explore 
heterogeneity among studies across different strata of exposure and confounding 
variables. Some of exposure and confounder variable strata could be responsible for 
heterogeneity of results. Pooling of results could be done across exposure and 
confounder variable strata if these indicated no evidence of heterogeneity.
Published data was used to investigate heterogeneity of results. Age of participants, 
sample size, study methods, and geographical setting were some of major variables 
contributing to heterogeneity of results. The DerSimonian and Laird Q statistic 
revealed that Altet et al12 and Alcaide et al10 were measuring the same underlying 
exposure effect. Homogeneity in these studies may be explained by the similarity in 
methodology, study setting and a minor difference in age range.
Studies by Lam et al9 and Liu et al3 were also homogeneous. Reasons for this include 
similarity in objectives, methodology, study participants and definition of cases.
There was also no evidence of heterogeneity between studies by Busking et al11 and 
Alcaide et al10. These studies were done in very different settings; USA and Spain,
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respectively. Major similarities between these two studies were the case definition, 
method of recruiting controls and overlapping of age ranges of study participants.
Evidence of homogeneity across study sub-groups warranted the pooling of results. A 
Mantel Haenszel weighted odds ratios was determined other than calculating crude 
OR from pooled data to avoid treating data from individual studies as if it arose from 
a single study31. Averaging summary statistics ensured that cases and controls within 
each study were compared directly, and that consistency of results between studies 
could be investigated31.
4.2 VALIDITY OF STUDIES INCLUDED IN THIS REVIEW 
Selection Bias
Selection bias cannot be ruled out in all the case control studies in this review. The 
source population from where cases originated could be different from the population 
where controls came from. The case control study by Buskin et al11 was clinic-based. 
Cases were PTB patients seeking clinic care. They enrolled patients seeking clinic 
care for other diseases as controls. The problem with selection of clinic-based controls 
is the possibility that they are not selected independently of exposure distribution in 
the source population32. Patients seeking care at the clinic could not be representative 
of the source population in terms of number of cigarettes smoked per day, previous 
exposure to tobacco smoke and duration of smoking, since they are not randomly 
selected32. Alcaide et al10 and Altet et al12 recruited contacts of diagnosed index PTB 
patients at the TB clinic as subjects for their respective studies.
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Lam et al9 and Liu et al3 did not initially design their studies to assess the relationship 
between tobacco and TB, but to look at all causes of deaths attributed to tobacco. 
Attention in these studies was likely much focussed on selection of appropriate 
controls for main neoplastic and vascular diseases such as lung cancer, liver cancer, 
stroke and ischaemic heart disease. PTB only contributed 5 % of all causes of deaths 
attributed to tobacco in the study by Liu et al3 and less than 1% in the study by Lam et 
al9.
Measurement bias
Exposure misclassification is a problem in case control studies. It is likely in case 
control studies to get differential exposure information for cases and controls; with 
more accurate information gathered for cases (on smoking habits for instance). All 
studies in this systematic review used questionnaires and interviews to collect 
exposure data. In addition to use of questionnaires, Altet et al12 and Alcaide et al10 
collected information on exposure by measuring urinary concentration of cotinine 
(ng/ml) in cases and controls to validate exposure data. Lam et al9 and Liu et al3 
gathered data on smoking habits 10 years before deaths of subjects occurred. 
Collecting information on smoking habits practiced 10 years later could be difficult. 
However it is worth endeavouring so that latency of exposure is taken into account. 
Reporter bias might have been minimised by Lam et al9, because informants were 
blinded on the variables of prime interest (smoking habits). Furthermore Lam et al9 
minimized recall bias by using living controls unlike Liu et al3 who used dead 
controls. In the study by Liu et al3 informants for patients who died of PTB are more 
likely to give more information on the smoking habits of the subject than those whose
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relatives/friends died of other conditions such as injuries. However Liu et al3 reported 
that information on smoking habits for 453 deaths in Shanghai, one of Chinese 
counties included in their study, was not different from that collected in a previous 
study despite differences in types of informants3.
Confounding
All studies in this systematic review used multivariate analysis to determine ORs or 
RRs and to control for confounding variables. Univariate analysis on the association 
under study can be misleading since it can give false significant ORs. However in the 
study by Altet et al12, crude OR=5.3 was not significantly different from an adjusted 
OR=5.4 (adjusted for sex, age, SES, crowding). This shows that sex, age, SES and 
crowding did not have significant confounding effects in this primary study. Similarly 
Alcaide et al10 reported a crude OR=3.6, which was equal to an adjusted OR=3.6, 
whereby sex, age and SES were controlled for. Though some studies did not control 
for important confounders such as HIV/AIDS and alcohol consumption, findings were 
similar across studies, in terms of direction of the association between tobacco smoke 
and PTB.
Alcohol is an important risk factor for PTB and may be related to other risk factors for 
PTB such as poor eating habits, tobacco and homelessness11’22. Misclassification of 
this exposure could result in false associations between PTB and other factors 
including tobacco smoking and homelessness. Apart from studies by Buskin et al", 
Doll et al1 and Altet et al12 (Altet et al did not need to control for alcohol) the rest did 
not indicate adjusting for alcohol in the analysis. Buskin et al11 who adjusted for 
alcohol indicated that tobacco was a significant risk factor for PTB in subjects who
44
smoked for durations of greater than 20 years11. However studies that did not control 
for alcohol indicated that tobacco smoking was a risk factor even in smokers of 
durations of less than 10 years3,9,10. This shows that differences in adequacy of 
controlling for major confounders across studies can lead to different results. Buskin 
et al11 demonstrated that false associations might be observed between tobacco 
smoking and disease due to confounding. They also showed that tobacco works 
synergistically with alcohol in their roles as risk factors for tuberculosis; a finding 
also reported by Birong et al.21
Since Lam et al9, Liu et al3 and Doll et al1 aimed at investigating all causes of 
mortality attributed to tobacco, collection of data on confounders specific to PTB was 
minimal. Controlling for confounding in these studies was however fair because 
logistic regression models and stratified data analysis methods were used to adjust for 
age, education, gender and number of cigarettes smoked per day1,3,9.
4.3 STRENTH OF EVIDENCE OF A CAUSAL RELATION SHIP 
Study design
Apart from the British cohort study the rest of studies in this review were case-control 
studies, which cannot give conclusive evidence on the casual relationship between 
tobacco smoke and PTB. However these studies gathered information that can be 
improved upon, and used to conduct high quality prospective studies. Studies in this 
review have highlighted risk groups for exposure to passive and active tobacco 
smoking who are also at a potential risk of developing PTB. Prospective studies can
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be done to assess the risk of PTB among cohorts of children aged between 0 to 10 
years old whose both parents smoke, or whose mothers or fathers smoke. Passive 
smoking is an important confounder when investigating the relationship between 
tobacco smoking and PTB. If passive smokers are included in the non-smokers 
category in a study investigating the relationship between PTB and tobacco there may 
be a dilution effect of the risk estimate (towards the null). Cohorts of active smokers 
who are exposed to passive smoking and those not exposed to passive smoking also 
need to be followed up to compare rates of development of PTB.
This review has assessed and noted study methods that can be used to get better 
results. These include use of PTB patients other than deaths, recruitment of tuberculin 
positive subjects especially for prospective studies, use of assay by gas-liquid 
chromatography to detect cotinine concentrations to accurately ascertain exposure to 
tobacco smoke,33 use of cohort other than case-control designs, blinding of subjects on 
the variables of interest during interviews or in the questionnaires, collecting data on 
passive smoking and adjusting for it in analysis along with other important 
confounders.
All studies in this review were done in average and high-income countries. 
Prospective studies should also be done in low-income countries, where PTB 
incidence is high, to get an adequate number of PTB subjects. Prospective studies to 
be done in developed countries should enrol subjects that are tuberculin positive other 
wise reference groups could be people who are not at risk of developing PTB at all.
46
Dose response
All studies in this review demonstrated a dose response relationship between number 
of cigarettes smoked per day and PTB morbidity or mortality. Liu et al3 showed that 
there was a dose response relationship between age when subject started smoking and 
the risk of dying from PTB . Altet et al observed that passive exposure both within 
and outside the home (whereby active smokers were family members) increased the 
risk of development of disease. Alcaide et al10 revealed that the effect of both active 
and passive tobacco smoking result into higher risk than active smoking alone and 
passive smoking alone.
Temporality
The impediment in case control studies is that the conviction in the results is minimal 
because temporality cannot be confidently established. Alcaide et al10 and Altet et al12 
enrolled incident cases that were contacts of index PTB patients seeking care at a TB 
clinic. Chances are high that exposure to tobacco smoke occurred prior to occurrence 
of PTB among those exposed. Lam et al9 and Liu et al3 gave an allowance of latency 
of exposure by getting information on dead persons’ smoking habits 10 years before 
the date of mortality from PTB. Again it is likely that smoking occurred prior to 
development of PTB for cases that were smokers.
Consistency in results and strength of association
All studies in this systematic review gave consistent results though they were done in 
very different settings. All the studies showed a moderate relationship between
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tobacco smoking and PTB. All of them statistically proved dose response 
relationships. Effects of exposure were however more pronounced in specific risk 
groups. However Birong et al21 whose study was available in Chinese, and only the 
abstract was in English, reported that tobacco and alcohol were not independently 
associated with PTB. They indicated that tobacco smoking and alcohol had a joint 
relationship with PTB as reported in section 1.3.4, pagel7 of this review.
Alcaide et al10 reported a much stronger association for daily smokers who were also 
exposed to passive smoking, OR=5.6 (95% Cl 2.07 to 15.10). Altet et al12 indicated a 
very strong association in children aged 0-4, exposed to passive smoking, OR=12 
(95% Cl 2.3 to 43.0) seconded by those aged 5-9 years, OR =10.2 (95% Cl 1.1 to 62). 
Among those aged between 10 and 14, OR was 3.1 (95% Cl 0.83 to 11.3), comparing 
those exposed and those not exposed to passive smoking. These ORs were obtained 
after adjusting for age, sex and father’s social class using multiple logistic regression 
analysis. Exposure to passive smoking in children was also more significant when 
both parents were smokers, OR=7.4 (95% Cl 2.81 to 20.09).
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5 . CONCLUSION AND RECOMMENDATIONS
TB is a global public health problem and is the leading cause of mortality among 
infectious diseases. The incidence of TB has increased in the majority of countries 
primarily due to its association with HIV/AIDS epidemic and other conditions 
including migration, homelessness, and poverty. Tobacco smoking has been cited as a 
risk factor for TB in several studies. Tobacco kills about 4 million people a year 
worldwide through respiratory diseases including PTB, various neoplastic and 
cardiovascular diseases. Seventy percent (70%) of deaths arising from tobacco 
smoking will occur in developing countries by early 2030s. However few studies 
worldwide have assessed the association between tobacco smoke and TB and most of 
them were conducted in middle and high-income countries. It is therefore 
recommended that further studies be done on the association between TB and tobacco 
smoking.
Prospective cohort studies in countries with high PTB incidence (for example Sub- 
Saharan Africa, some parts of Asia and Eastern Europe) would show more convincing 
results on the association under study. Similar prospective studies done in high- 
income developed countries should recruit tuberculin positive subjects. Such studies 
must have adequate sample sizes and should control for all major confounding 
variables including previous exposure to tobacco, height, weight, passive smoking, 
duration of exposure, alcohol consumption, health history, HIV/AIDS, homelessness 
and SES.
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This systematic review is important because it provides added weight and confidence 
to arguments showing that tobacco smoking is associated with PTB. Currently the 
issue of the relationship between tobacco smoking and PTB is not resolved in the 
English literature. According to findings from this systematic review, the overall 
association is moderate, but strong for specific risk groups in different populations. 
These include children under 10 years, smokers of durations greater than 20 years, 
children whose both parents are smokers, people exposed to both passive and active 
smoking, heavy smokers, smokers who take alcohol and the poor.
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6 . APPENDIX
The DerSimonian and Laird approach was used to assess homogeneity across 
subgroups of studies24. Using this approach studies included in this systematic review 
were regarded as a sample from a population of possible studies with mean effect (p) 
and a population variance (A ). The population variance represents the degree to 
which exposure effects vary across studies. Constancy of exposure effect 
(homogeneity) was evaluated with the DerSimonian and Laird Q statistic. The test 
statistic Q is the sum of squares of deviations of exposure effect for each study (y) 
about the weighted mean effect estimator of studies included in meta-analysis (yw). 
The weighted mean (yw) may be regarded as a sample mean. The squares of the 
deviations are each multiplied by a weight (vy), which is the reciprocal of each study’s 
sampling variance of natural log OR 24,25.
Under the null hypothesis of constant effect across studies (Ho: A2 = 0), Q is regarded 
as a chi-square statistic with k-1 degrees of freedom, where k is the number of studies. 
A low p-value for this statistic indicates the presence of heterogeneity, which 
undermines the validity of pooled risk estimates. The cut off point of a=0.05 was 
used. ORs were combined using the Mantel-Haenszel fixed effect model26 for 
subgroups that were found to be homogeneous. This model assumes the existence of a 
constant effect of exposure common to all studies included in a meta-analysis26. 
Calculations were done using Epi Info version 6c and Microsoft Excel computer 
packages.
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Full meanings of headings of column in tables 6.1 through 6.5 
(Tables 6.1 to 6.5 show how the Q statistic was calculated)
rt 
rc
y
variance
Wi 
Wjyt
y
Wi(yry)2 
w%
If number of smokers in each study = nt 
And non-smokers = nc;
Variance of loge OR can be estimated24 as
Si2= O^hO-r,,)]'1 + [ncirci{\-rc) \ x
The weighted estimator24 of treatment effect
y  =Zwiyu'Zwi
The Q statistic = Xw(yi- yw)2
= proportion of PTB patients among smokers 
= proportion of PTB patients among non-smokers
= natural logarithm of OR (logeOR). It is the estimate of exposure effect in 
each study
^variance of the OR in the logarithmic scale (var( logeOR))
^inverse of variance of natural log OR, it is the weight for each study 
=the product of weight and loge OR
= weighted estimator of exposure among studies in meta-analysis 
= product of weight and squared deviation of each study’s y  from the 
weighted estimate (y) of exposure effect 
= weight percent for each study
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Table 6.1 Heterogeneity assessment across all studies included in this systematic 
review
Study Smokers Non-sm okers Crude
OR rt r c variance W i w % W i y i w (y r y YP T B n o P T B P T B n o P T B
A lte t12 83 58 10 37 5.29 0.59 0.21 1.667 0.156 6.4 0.928 10.663 9.2079
Alcaide10 33 19 13 27 3.61 0.63 0.33 1.283 0.197 5.08 0.737 6.5159 3.3814
B u s k in 11 103 300 48 245 1.75 0.26 0.16 0.561 0.038 26.3 3.823 14.78 0.2328
L iu 3 2371 18544 1003 12165 1.55 0.11 0.08 0.439 0.002 643 93.32 282.16 0.5139
L a m 9 36 841 11 639 2.49 0.04 0.02 0.911 0.121 8.23 1.195 7.5011 1.6228
D o ll1 44 4 - - 0.92 - - - - - -
T O T A L 6 8 9 3 2 1 .6 2 1 4 .9 5 9
Table 6.2 Heterogeneity assessment and meta-analysis of case-control studies 
investigating the association between PTB mortality and tobacco smoking in Chinese 
subjects aged between 35 years to 69 years.
Study Smokers Non-sm okers Crude
OR rt rc Yi v a r ia n c e Wi w % im w i ( y - y ) 2P TB n o P T B P T B n o P T B
L iu 3 2371 18544 1003 12165 1.551 0.113 0.076 0.439 0.00155 643.13 98.736 282.16 0.0253
L a m 9 36 841 11 639 2.487 0.041 0.017 0.911 0.12144 8.2345 1.2642 7.5011 1.7877
T O T A L 6 5 1 .3 6 2 8 9 .6 6 1 .8 1 2 9
Table 6.3 Heterogeneity assessment and meta-analysis of case-control studies 
investigating the association between PTB morbidity and tobacco smoking in subjects 
of all ages
Study Sm okers Non-sm okers Crude
OR rt rc V' v a r ia n c e Wi w % wiyi W '( y - y ) 2P T B n o P T B P T B n o P T B
A lte t12 83 58 10 37 5.29 0.59 0.21 1.6667 0.156317 6.4 17 10.66 4.3197
A lc a id e 10 33 19 13 27 3.61 0.63 0.33 1.283 0.196895 5.08 13 6.516 0.974153
B u s k in 11 103 300 48 245 1.75 0.26 0.16 0.561 0.037957 26.3 70 14.78 2.124873
T O T A L 37.8 31.96 7.418726
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Table 6.4 Heterogeneity assessment and meta-analysis of case-control studies 
investigating the association between PTB morbidity and active tobacco smoking in 
subjects aged 17 years and above.
Study Smokers Non-sm okers Crude
OR n h y> v a r ia n c e Wi W % w iy i w i ( y - y ) 2P T B n o P T B P T B n o P T B
A lc a id e 10 33 19 13 27 3.607 0.63 0.33 1.283 0.1969 5.079 16.16 6.516 1.85872
B u s k in 11 103 300 48 245 1.752 0.26 0.16 0.561 0.038 26.35 83.84 14.78 0.36062
T O T A L 31.42 21.3 2.21934
Table 6.5 Heterogeneity assessment and meta-analysis of case-control studies 
investigating the association between PTB morbidity and tobacco smoking in Spanish 
subjects aged 25 years and below
Study Sm okers Non-sm okers Crude
OR rt rc Yi v a r ia n c e W i w % im w ( y - y ) 2P T B n o P T B P T B n o P T B
A lte t12 83 58 10 37 5.295 0.59 0.213 1.6667 0.156 6.4 55.7 10.60 0.17784
Alcaide10 33 19 13 27 3.607
0.63
5 0.325 1.283 0.197 5.08 44.3 6.516 0.23926
T O T A L 1 1 .5 1 7 .1 8 0 .4 1 7 0 9
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